Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Lipid dyshomeostasis is associated with the most common form of dementia, Alzheimer's disease (AD). Substantial progress has been made in identifying positron emission tomography and cerebrospinal fluid biomarkers for AD, but they have limited use as front‐line diagnostic tools. Extracellular vesicles (EVs) are released by all cells and contain a subset of their parental cell composition, including lipids. EVs are released from the brain into the periphery, providing a potential source of tissue and disease specific lipid biomarkers. However, the EV lipidome of the central nervous system is currently unknown and the potential of brain‐derived EVs (BDEVs) to inform on lipid dyshomeostasis in AD remains unclear. The aim of this study was to reveal the lipid composition of BDEVs in human frontal cortex, and to determine whether BDEVs have an altered lipid profile in AD. Using semi‐quantitative mass spectrometry, we describe the BDEV lipidome, covering four lipid categories, 17 lipid classes and 692 lipid molecules. BDEVs were enriched in glycerophosphoserine (PS) lipids, a characteristic of small EVs. Here we further report that BDEVs are enriched in ether‐containing PS lipids, a finding that further establishes ether lipids as a feature of EVs. BDEVs in the AD frontal cortex offered improved detection of dysregulated lipids in AD over global lipid profiling of this brain region. AD BDEVs had significantly altered glycerophospholipid and sphingolipid levels, specifically increased plasmalogen glycerophosphoethanolamine and decreased polyunsaturated fatty acyl containing lipids, and altered amide‐linked acyl chain content in sphingomyelin and ceramide lipids relative to CTL. The most prominent alteration was a two‐fold decrease in lipid species containing anti‐inflammatory/pro‐resolving docosahexaenoic acid. The in‐depth lipidome analysis provided in this study highlights the advantage of EVs over more complex tissues for improved detection of dysregulated lipids that may serve as potential biomarkers in the periphery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099
Self-citationB lymphocytes secrete antigen-presenting vesicles.
Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., & Geuze, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1161 · Cited by 3,546 · cited 1×
“Exosomes are small extracellular vesicles (EVs) released from cells upon fusion of the multi-vesicular body (MVBs) with the plasma membrane (Johnstone et al., 1987, Raposo et al., 1996).”
BackgroundJohnstone, R. M., Adam, M., Hammond, J. R., Orr, L., & Turbide, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48095-7 · Cited by 2,931 · cited 1×
“Exosomes are small extracellular vesicles (EVs) released from cells upon fusion of the multi-vesicular body (MVBs) with the plasma membrane (Johnstone et al., 1987, Raposo et al., 1996).”
BackgroundGlypican-1 identifies cancer exosomes and detects early pancreatic cancer
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., et al. (2015) · Nature · doi:10.1038/nature14581 · Cited by 2,880 · cited 1×
“Recent studies have revealed exosomal proteins as potential biomarkers in non-small cell lung cancer and pancreatic cancer (Li et al., 2017, Melo et al., 2015) and certain lipid species in urinary exosomes have been reported to serve as biomarkers for prostate cancer diagnosis (Skotland et al.,…”
BackgroundCurrent knowledge on exosome biogenesis and release
Hessvik, N. P., & Llorente, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2595-9 · Cited by 2,362
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344 · cited 1×
“The C22:6 is the most abundant PUFA chain in GP and it is derived from docosahexaenoic acid, DHA, which is the precursor of a group of beneficial bioactive anti-inflammatory pro-resolving mediators (Serhan and Levy, 2018, Whittington et al., 2017).”
BackgroundAlzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343 · cited 1×
“As BDEVs are predicted to participate in AD pathogenesis (DeLeo and Ikezu, 2018, Kanninen et al., 2016, Rajendran et al., 2006, Sharples et al., 2008, Thompson et al., 2016, Vella et al., 2016, Vingtdeux et al., 2012), we hypothesized that EVs could provide a rich source of lipids that reflect…”
BackgroundConsumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135 · cited 1×
“The decreased C22:6 content in AD BDEVs in this study supports DHA deficiency in AD, a known feature of the disease (Morris et al., 2003, Tully et al., 2003) and suggest that’s that the level of C22:6 in BDEVs could serve as a peripheral marker of AD.”
BackgroundLipids in exosomes: current knowledge and the way forward
Skotland, T., Sandvig, K., & Llorente, A. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.03.001 · Cited by 1,030 · cited 5×
“In agreement with these studies (Haraszti et al., 2016, Laulagnier et al., 2004, Llorente et al., 2013, Skotland et al., 2017a, Skotland et al., 2017b, Trajkovic et al., 2008, Chan et al., 2012, Chen et al., 2019, Lydic et al., 2015), we show that human frontal cortex derived EVs are enriched in PS…”
BackgroundResultInfluentialDyall, S. C. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00052 · Cited by 943
Haraszti, R. A., Didiot, M., Sapp, E., Leszyk, J., Shaffer, S. A., Rockwell, H. E., Gao, F., Narain, N. R., DiFiglia, M., Kiebish, M. A., et al. (2016) · Journal of Extracellular Vesicles · doi:10.3402/jev.v5.32570 · Cited by 746
Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology
Skotland, T., Hessvik, N. P., Sandvig, K., & Llorente, A. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r084343 · Cited by 730
Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer Disease
Chan, R. B., Oliveira, T. G., Cortes, E. P., Honig, L. S., Duff, K. E., Small, S. A., Wenk, M. R., Shui, G., & Di Paolo, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274142 · Cited by 630 · cited 2×
“…with these studies (Haraszti et al., 2016, Laulagnier et al., 2004, Llorente et al., 2013, Skotland et al., 2017a, Skotland et al., 2017b, Trajkovic et al., 2008, Chan et al., 2012, Chen et al., 2019, Lydic et al., 2015), we show that human frontal cortex derived EVs are enriched in PS lipids.”
BackgroundResultHan, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00997.x · Cited by 626 · cited 1×
“…reported in previous studies are partially conflicting, likely due to the differences in brain region, disease severity and comorbidity, etc. (Han et al., 2002, Bandaru et al., 2009, Cutler et al., 2004, Han et al., 2001, He et al., 2010, Kosicek and Hecimovic, 2013, Pettegrew et al., 2001,…”
ResultDeregulation of sphingolipid metabolism in Alzheimer’s disease
He, X., Huang, Y., Li, B., Gong, C.-X., & Schuchman, E. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.010 · Cited by 516
Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers
Thompson, A. G., Gray, E., Heman-Ackah, S. M., Mäger, I., Talbot, K., Andaloussi, S. E., Wood, M. J., & Turner, M. R. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.68 · Cited by 431 · cited 1×
“…BDEVs are predicted to participate in AD pathogenesis (DeLeo and Ikezu, 2018, Kanninen et al., 2016, Rajendran et al., 2006, Sharples et al., 2008, Thompson et al., 2016, Vella et al., 2016, Vingtdeux et al., 2012), we hypothesized that EVs could provide a rich source of lipids that reflect…”
BackgroundHan, X., Rozen, S., Boyle, S. H., Hellegers, C., Cheng, H., Burke, J. R., Welsh-Bohmer, K. A., Doraiswamy, P. M., & Kaddurah-Daouk, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021643 · Cited by 429 · cited 2×
“It has previously been reported that lipid metabolism is extensively reprogrammed in AD as detected in brain, cerebrospinal fluid (CSF) and blood (Han et al., 2011, He et al., 2010, Kosicek and Hecimovic, 2013, Mielke et al., 2014, Mielke and Lyketsos, 2010, Wong et al., 2017, Wood, 2012, Mielke et…”
BackgroundExtracellular vesicles: lipids as key components of their biogenesis and functions
Record, M., Silvente-Poirot, S., Poirot, M., & Wakelam, M. O. (2018) · Journal of Lipid Research · doi:10.1194/jlr.e086173 · Cited by 328 · cited 2×
“PS lipids make up a substantial proportion of the EV membrane and are proposed to play a role in facilitating EV uptake by recipient cells (Kastelowitz and Yin, 2014, Laulagnier et al., 2004, Record et al., 2014, Record et al., 2018, Wei et al., 2016, Matsumura et al., 2019, Sharma et al., 2017).”
BackgroundWhat are lipoproteins doing in the brain?
Wang, H., & Eckel, R. H. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.10.003 · Cited by 234 · cited 1×
“Encouragingly, the BDEVs were not abundant in GL or cholesterol ester (CE) lipids, suggesting limited lipoprotein contamination (Serna et al., 2015, Sun et al., 2019, Wang and Eckel, 2014).”
BackgroundDysregulation of lipids in Alzheimer’s disease and their role as potential biomarkers
Wong, M. W., Braidy, N., Poljak, A., Pickford, R., Thambisetty, M., & Sachdev, P. S. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.008 · Cited by 223
Plasmalogens and Alzheimer’s disease: A review
Su, X. Q., Wang, J., & Sinclair, A. J. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1044-1 · Cited by 172
Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Schech, S., Carrick, R., Carlson, M. C., Mori, S., Miller, M. I., Ceritoglu, C., Brown, T., et al. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.014 · Cited by 170
Lipidomics of Alzheimer's disease: current status
Wood, P. L. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt103 · Cited by 167
Potential Contribution of Exosomes to the Prion-Like Propagation of Lesions in Alzheimer’s Disease
Vingtdeux, V., Sergeant, N., & Buée, L. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00229 · Cited by 116
Plasmalogens rescue neuronal cell death through an activation of AKT and ERK survival signaling
Hossain, M. S., Ifuku, M., Take, S., Kawamura, J., Miake, K., & Katafuchi, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083508 · Cited by 116 · cited 1×
“Plasmalogens could play an active role in scavenging oxidative stress and reducing inflammatory responses in recipient cells with studies showing that PE-P can rescue neuronal cell death (Hossain et al., 2013, Wood et al., 2010).”
BackgroundSun, Y., Saito, K., & Saito, Y. (2019) · Metabolites · doi:10.3390/metabo9110259 · Cited by 64
Cited by
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433
Ghadami, S., & Dellinger, K. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1198044 · Cited by 246
“glycerophospholipids, and lower sphingolipids (Su et al., 2021).”
BackgroundEmergence of Extracellular Vesicles as “Liquid Biopsy” for Neurological Disorders: Boom or Bust
Kumar, A., Nader, M. A., & Deep, G. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000788 · Cited by 79
“In addition to profiling proteins and miRNA cargos, lipid analysis of EVs, predominantly isolated from brain tissue, has also provided evidence of dysregulation in AD samples, which can be attributed to lipid imbalance in AD (Wang et al., 2012; Cohn et al., 2021; Su et al., 2021).”
BackgroundCao, Y., Zhao, L.-W., Chen, Z.-X., & Li, S.-H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1430465 · Cited by 65
“One prior in-depth lipidomic analysis revealed that the lipid composition of brain-derived EVs (BDEVs) in the human frontal cortex is altered in AD (Su et al., 2021).”
BackgroundHe, S., Xu, Z., & Han, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00803-6 · Cited by 62
Metadata
- Authors
- Su, H., Rustam, Y. H., Masters, C. L., Makalic, E., McLean, C. A., Hill, A. F., Barnham, K. J., Reid, G. E., & Vella, L. J.
- Venue
- Journal of Extracellular Vesicles
- Publisher
- Wiley
- Published
- 2021-05
- Volume
- 10
- Issue
- 7
- Pages
- e12089-e12089
- ISSN
- 2001-3078 (ISSN-L)
- OpenAlex
- W3161995182
- Cited by
- 188
- References
- 26
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.